TLR7 tolerance is independent of the type I IFN pathway and leads to loss of anti-tumor efficacy in mice.

Autor:	Koga-Yamakawa, Erina, Murata, Masashi, Dovedi, Simon, Wilkinson, Robert, Ota, Yosuke, Umehara, Hiroki, Sugaru, Eiji, Hirose, Yuko, Harada, Hideyuki, Jewsbury, Philip, Yamamoto, Setsuko, Robinson, David, Li, Chiang
Předmět:	TOLL-like receptors ANTINEOPLASTIC agents DRUG efficacy CANCER immunotherapy LABORATORY mice
Zdroj:	Cancer Immunology, Immunotherapy; Oct2015, Vol. 64 Issue 10, p1229-1239, 11p
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink